Skip to main content

Table 3 Gram-negative bacterial resistance and antibiotic effectiveness of Gram-negative specific antibiotics against the tested bacteria

From: Mapping pathogenic bacteria resistance against common antibiotics and their potential susceptibility to methylated white kidney bean protein

Antibiotics disk

Category &inhibition zone (mm)a

Classification of Tested bacteria (S, I & R)baccording to Inhibition zone (mm)

% Antibiotic effectiveness (AE)c

S

R

E. c1

E. c2

E. c3

K. p1

K. p2

K. p3

K. oxytoca

S. Typhimuriam

Shigella sp

P. aeruginosa

Pro mirabilis

Ampicillin – sulbactam(20 µg)

 ≥ 15

 ≤ 13

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (2)

R (2)

R (0)

R (1)

0%

Cefepime (30 µg)

 ≥ 25

 ≤ 18

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (4)

R (3)

R (0)

R (1)

0%

Meropenem (10 µg)

 ≥ 23

 ≤ 19

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (4)

R (5)

R (6)

R (2)

0%

Gentamycin(10 µg)

 ≥ 15

 ≤ 12

S (25)

S (23)

S (20)

S (20)

R (0)

S (16)

S (19)

R (8)

R (5)

S (17)

R (5)

63.64%

Tetracycline (30 µg)

 ≥ 15

 ≤ 11

R (0)

R (0)

R (0)

R (0)

I (12)

R (0)

S (16)

S (18)

S (17)

R (10)

R (1)

27.27%

Azithromycin (5 µg)

 ≥ 13

 ≤ 11

R (0)

S (15)

R (0)

R (0)

R (0)

R (0)

R (0)

R (11)

R (9)

S (2)

R (4)

18.19%

Trimethoprim (5 µg)

 ≥ 16

 ≤ 10

R (0)

R (0)

R (0)

S (20)

R (0)

S (20)

S (24)

S (23)

S (23)

R (8)

R (9)

45.55%

Colistin (10 µg)

 ≥ 11

 ≤ 10

R (9)

R (10)

R (7)

R (8)

R (8)

R (4)

R (8)

R (8)

R (5)

R (0)

R (1)

0%

Fosfomycin (10 µg)

 ≥ 16

 ≤ 12

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (0)

R (2)

R (2)

R (0)

R (0)

0%

Chloramphenicol(30 µg)

 ≥ 18

 ≤ 12

S (27)

S (25)

S (20)

R (2)

S (20)

R (0)

S (22)

S (26)

S (30)

S (22)

S (17)

81.82%

Nitrofurantoin(300 µg)

 ≥ 18

 ≤ 12

I (14)

I (14)

I (14)

R (10)

R (0)

R (0)

R (5)

I (16)

I (16)

R (10)

R (4)

0%

Ciprofloxacin(5 µg)

 ≥ 26

 ≤ 21

R (18)

R (4)

R (16)

R (10)

R (8)

R (8)

I (22)

R (16)

R (15)

R (13)

R (18)

0%

MAR INDEXd

 

0.75

0.67

0.67

0.83

0.83

0.83

0.58

0.67

0.67

0.75

0.92

 
  1. a(EM100 connect – CLSI M100 ED30, 2020)
  2. bS, I & R (Sensitive, Intermediate & Resistant)
  3. cAE Antibiotic effectiveness % = (No of Sensitive strain/total No of strain)
  4. dMulti antibiotics resistant MAR = a/b, where a represents the number of antibiotics to which the test isolate depicted resistance and b represents the total number of antibiotics to which the test isolate has been evaluated for susceptibility